Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
Pharmaceutical Business Review
Fri, 08/7/20 - 11:10 am
Daiichi Sankyo
AstraZeneca
patritumab deruxtecan
Tagrisso
non-small cell lung cancer
clinical trials
Elevation Oncology launches with $32.5 million Series A, gives new life to former Merrimack program
Endpoints
Tue, 07/21/20 - 10:58 am
Elevation Oncology
Merrimack
seribantumab
non-small cell lung cancer
NovoCure, Merck Team Up on Phase II Lung Cancer Trial
BioSpace
Wed, 07/15/20 - 11:16 pm
Merck
Novocure
clinical trials
tumor treating fields
Keytruda
non-small cell lung cancer
Daiichi Sankyo and Thermo Fisher Partner on Companion Diagnostic Device for NSCLC
BioSpace
Tue, 06/23/20 - 11:39 pm
Daiichi Sankyo
Thermo Fisher
companion diagnostics
diagnostics
non-small cell lung cancer
NICE backs funding for Roche’s lung cancer drug after price cut
Pharmaforum
Mon, 06/15/20 - 10:21 am
NICE
Roche
Rozlytrek
non-small cell lung cancer
Marketing Lilly's Cyramza, after split decision from FDA advisers, wins first-line lung cancer nod
Fierce Pharma
Mon, 06/1/20 - 11:34 pm
Eli Lilly
Cyramza
FDA
non-small cell lung cancer
Ahead of ASCO, Bristol Myers Squibb Announces Results for Three Clinical Trials
BioSpace
Thu, 05/14/20 - 10:56 pm
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
ide-cel
Multiple Myeloma
Bluebird Bio
ASCO 2020
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation
Xconomy
Thu, 05/7/20 - 12:29 am
Novartis
Tabectra
FDA
non-small cell lung cancer
capmatinib
AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy
Endpoints
Mon, 04/13/20 - 11:06 am
AstraZeneca
Tagrisso
clinical trials
non-small cell lung cancer
BMS' Opdivo gets another lung cancer shot as FDA, EMA accept chemo combo filings
Fierce Pharma
Wed, 04/8/20 - 11:40 pm
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
FDA
Europe
priority review
EMA
In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug
Endpoints
Wed, 03/25/20 - 10:45 am
Novartis
Merck KGaA
Japan
tepotinib
non-small cell lung cancer
Lilly’s Cyramza closer to first-line lung cancer use after ODAC verdict
Pharmaforum
Thu, 02/27/20 - 10:23 am
Eli Lilly
Cyramza
non-small cell lung cancer
FDA
advisory panels
Takeda’s ALUNBRIG gets FDA priority review for expanded indication in NSCLC
Pharmaceutical Business Review
Tue, 02/25/20 - 10:19 am
Takeda
Alunbrig
brigatinib
FDA
priority review
non-small cell lung cancer
FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq
Motley Fool
Thu, 02/20/20 - 10:44 am
Roche
FDA
priority review
Tecentriq
non-squamous non-small cell lung cancer
non-small cell lung cancer
Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche — delighting Incyte execs
Endpoints
Tue, 02/11/20 - 10:28 am
Incyte
Novartis
FDA
capmatinib
prioirty review
non-small cell lung cancer
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Motley Fool
Sun, 02/2/20 - 11:51 pm
Bristol-Myers Squibb
Europe
Opdivo
Yervoy
non-small cell lung cancer
Racing Blueprint, Lilly drug gets priority review for RET hopeful
Fierce Biotech
Wed, 01/29/20 - 10:35 am
Eli Lilly
FDA
Blueprint Medicines
selpercatinib
LOXO-292
thyroid cancer
non-small cell lung cancer
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market
BioSpace
Thu, 01/23/20 - 12:22 pm
BeiGene
tiselizumab
non-small cell lung cancer
Merck
Keytruda
Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint
TheStreet.com
Thu, 12/26/19 - 01:16 pm
Spectrum Pharma
lung cancer
clinical trials
poziotinib
non-small cell lung cancer
ESMO I-O: Roche silences Tecentriq doubters with latest lung cancer analysis
Fierce Pharma
Tue, 12/17/19 - 09:29 pm
ESMO
Roche
Tecentriq
non-small cell lung cancer
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »